Webinar – KioMedine^vsone in Practice: Insights from an Orthopedic Surgeon

13 February 2025

Osteoarthritis, particularly in active and athletic patients, presents a significant clinical challenge. When conventional treatments such as corticosteroid, hyaluronic acid, or PRP injections fail, what alternative therapeutic options can be considered?

On Monday, March 24, 2025, at 7:00 PM CET, Prof. Thomas Neri and Dr. Benoit Bouthin will share their insights on the potential of carboxymethyl-chitosan (CM-Chitosan), a biomaterial derived from the button mushroom, in the treatment of osteoarthritis patients.

Presentation by Prof. Thomas Neri

Prof. Thomas Neri wil present a review of the literrature on carboxymethyl-chitosan (CM-Chitosan), a molecule derived from button mushroom (agaricus bisporus), in managing osteoarthritic and athletic patients. He will also share his experience in using CM-Chitosan in his orthopedic surgeon practice.

Presentation by Dr. Benoit Bouthin

Dr. Benoît Bouthin will present the preliminary results of the currently ongoing clinical study with CM-Chitosan on refractory OA patients to corticosteroids, hyaluronic acid and PRP.

Discussion topics

✔ Patient profiles: athletic patients and active seniors (>50 years old) with treatment-resistant osteoarthritis.

✔ Case studies and clinical practice protocols: how to integrate this innovation into a comprehensive treatment strategy?

Practical Information

📅 Date: Monday, March 24, 2025
⏰ Time: 7:00 PM – 7:45 PM CET
💻 Format: Live webinar with interactive Q&A

Who Should Attend?

Sports medicine physicians, orthopedic surgeons, rheumatologists, physiotherapists, and rehabilitation specialists looking for innovative approaches to osteoarthritis management.

Why Join?

This webinar provides a unique opportunity to explore the potential of CM-Chitosan as an innovative treatment for active and athletic osteoarthritis patients.

📩 For inquiries, contact Fabrice Letimier at fabrice.letimier@kiomedpharma.com